Primary melanoma of the anorectal region: clinical and histopathological review of 17 cases. A retrospective cohort study

Abstract

Aim: The aim of our study was to scrutinize diagnostic and treatment factors that may contribute to the low survival rate from anorectal melanoma while adding 17 more cases to the global research database.Method: We carried out a retrospective analysis of 17 cases of anorectal melanoma treated at a single institution from 2000 to 2020. Data on patient age, sex, complaints, treatment and survival as well as tumour size, resection margins, histological and immu-nohistochemical features were assessed.Results: The median age of patients was 72 ± 12.49 (45– 92) years. Most of the patients were women (n = 11, 64.71%). Three (17.65%) patients underwent no radical treatment. Of eight patients treated initially with radical surgery (either total mesorectal excision or abdominoperineal resection), six (75%) were found to have positive lymph nodes. Mean survival was 20 ± 23.46 (1– 84) months. The average diameter of the resected tumours was 5.43 ± 3.02 cm (1.3– 10 cm). Most tumours had epithelioid or spindle cell morphol-ogy and were positive for one or more melanocytic markers (S100, HMB- 45 or MITF). More than half of the tumours contained no or very little melanin pigment. None of the tumours had significant lymphocytic infiltration. Three tumours showed positivity for keratins (PANCK or CAM5.2) and one tumour showed positivity for C- KIT stain.Conclusion: An aggressive surgical approach may have an effect on survival in most early stages while more advanced disease benefits from a more conservative approach. Attention to sentinel lymph nodes and further systemic research into therapy is required. For now, treatment and diagnostic modalities seem to be inconsistent, requiring further investigation to elucidate common points.